Nightmare Disorder, as categorized in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), is a sleep disorder characterized by frequent and recurring nightmares that cause significant distress or impairment in social, occupational, or other important areas of functioning. Individuals with Nightmare Disorder typically experience dreams that are vivid, detailed, and disturbing, often involving threats to survival, security, or physical integrity. These nightmares usually occur during the latter part of the sleep cycle, often in the second half of the night, and can lead to awakenings. Upon waking, the individual usually becomes rapidly oriented and alert, with a clear recollection of the nightmare, which can result in feelings of anxiety, fear, or sadness.

The distress from the nightmares can be significant, leading to sleep avoidance or anxiety around sleep, further exacerbating sleep disturbances. This can result in daytime symptoms such as fatigue, mood disturbances, and cognitive impairments due to the disrupted sleep patterns. It is important to note that occasional distressing dreams are not sufficient for a diagnosis of Nightmare Disorder. Instead, the frequency and intensity of the nightmares, along with the associated distress and impairment, are critical factors in diagnosis.

It is also relevant to consider that Nightmare Disorder can exist as a primary condition or as a secondary condition related to other mental health disorders, such as post-traumatic stress disorder (PTSD) or depression. Treatment for Nightmare Disorder often includes psychological therapies, such as imagery rehearsal therapy, cognitive-behavioral therapy, and sometimes medication management.

Diagnostic Criteria

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), outlines specific criteria for diagnosing Nightmare Disorder. These criteria include:

• Repeated occurrences of extended, extremely dysphoric, and well-remembered dreams that usually involve efforts to avoid threats to survival, security, or physical integrity and that generally occur during the second half of the major sleep episode.
• On awakening from the dysphoric dreams, the individual rapidly becomes oriented and alert.
• The sleep disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.
• The nightmare symptoms are not attributable to the physiological effects of a substance (e.g., a drug of abuse, medication) or another medical condition.
• Other mental disorders, including sleep disorders like sleep terror disorder or REM Sleep Behavior Disorder, cannot better explain the nightmares.

In the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition), specifiers provide additional detail about a disorder, which can help understand the severity, course, and other aspects. For Nightmare Disorder, the DSM-5 includes several specifiers:

• With Associated Non-Sleep Disorder: This specifier is used when the individual also has a diagnosable mental health disorder, such as anxiety disorder, depression, or post-traumatic stress disorder (PTSD). Nightmares may be a symptom or exacerbation of these conditions.
• With Associated Other Medical Condition: This specifier is used when a co-existing medical condition is relevant to the development or exacerbation of the Nightmare Disorder. Conditions like heart disease, respiratory disorders, or neurological conditions could be relevant.
• Acute/Subacute vs. Persistent: The DSM-5 distinguishes between acute (short-term), subacute, and persistent (chronic) forms of Nightmare Disorder. The acute form lasts for a minimum of one week and a maximum of one month; subacute lasts for more than one month but less than six months, while persistent lasts for six months or longer.
• Severity Specifiers: The DSM-5 also allows for the specification of the severity of the Nightmare Disorder, which is usually based on the frequency of the nightmares and the level of distress or impairment they cause. Severity can be categorized as mild, moderate, or severe.

These specifiers play a crucial role in understanding the full context of an individual's Nightmare Disorder, guiding treatment planning, and providing a more comprehensive view of the patient's condition. They also help in distinguishing Nightmare Disorder from other sleep disorders and mental health conditions with similar symptoms.

Research studies have provided insights into various aspects of Nightmare Disorder. A study by Aurora et al. (2010) emphasized the importance of distinguishing Nightmare Disorder from other sleep disorders, highlighting that the rapid alertness upon awakening is a distinctive feature of nightmares compared to non-REM sleep terrors, which are often characterized by confusion and disorientation upon waking. Similarly, Krakow and Zadra (2006) discussed the impact of nightmares on daytime functioning, noting that individuals with Nightmare Disorder often experience significant distress, fear of sleep, and avoidance behaviors that can lead to impaired daytime functioning. This is consistent with the DSM-5 criterion regarding the considerable distress or impairment caused by the nightmares.

Levin and Nielsen's (2007) review on disturbed dreaming and posttraumatic stress disorder (PTSD) provided valuable insights into the potential relationship between Nightmare Disorder and other mental health conditions. Their findings suggest that nightmares, exceptionally when recurrent and distressing, can be a symptom of PTSD, further complicating the diagnosis and treatment of Nightmare Disorder.

In summary, these studies and the DSM-5 criteria underscore the complexity of diagnosing and managing Nightmare Disorder, emphasizing the importance of a thorough clinical evaluation to differentiate it from other sleep or mental health disorders.

The Impacts

Nightmare Disorder can have a significant impact on an individual's mental and physical health, as well as their overall quality of life. The effects of frequent and distressing nightmares extend beyond the night and can influence various aspects of daytime functioning.

One of the primary impacts of Nightmare Disorder is on sleep quality. Nightmares often lead to disrupted sleep patterns, including difficulties in falling asleep or staying asleep. This fragmentation of sleep can result in chronic sleep deprivation, as noted in studies by Krakow and Zadra (2006). Such sleep disruptions can lead to excessive daytime sleepiness, fatigue, and impaired cognitive functions like concentration and memory, adversely affecting work or academic performance.

The psychological effects of Nightmare Disorder are also profound. Research has shown that individuals with frequent nightmares have a higher risk of developing anxiety and depressive symptoms. A study by Li et al. (2010) found a significant association between nightmare frequency and severity of depressive symptoms. The distress caused by nightmares can lead to a fear of going to sleep, further exacerbating the problem.

Moreover, Nightmare Disorder has been linked to an increased risk of suicidal ideation and behavior. Sjöström et al. (2009) reported that individuals experiencing frequent nightmares were more likely to exhibit suicidal tendencies, highlighting the importance of addressing mental health aspects in patients with Nightmare Disorder.

Additionally, there is evidence suggesting that Nightmare Disorder may exacerbate symptoms of existing mental health conditions, such as post-traumatic stress disorder (PTSD). Nadorff et al. (2013) emphasized the role of nightmares in maintaining and worsening PTSD symptoms, indicating the bidirectional relationship between nightmares and mental health disorders.

These studies collectively demonstrate that Nightmare Disorder is not just a nocturnal problem but a condition with far-reaching implications for daytime functioning and overall well-being. Effective management of Nightmare Disorder is crucial to mitigate these adverse impacts.

The Etiology (Origins and Causes)

The etiology of Nightmare Disorder is multifaceted, involving a complex interplay of psychological, physiological, and environmental factors. Research has identified several potential origins and causes of this disorder.

Psychological factors are significant in the development of Nightmare Disorder. Studies have shown a strong correlation between stress and the frequency of nightmares. A study by Levin and Nielsen (2007) indicated that stress, mainly when it is chronic or traumatic, can lead to an increase in nightmare frequency. This is likely due to the impact of stress on the brain, particularly areas involved in emotion regulation, such as the amygdala.

Traumatic experiences are also a well-established cause of nightmares. Hartmann (1998) proposed that nightmares are a form of re-experiencing traumatic events, which is consistent with the high prevalence of nightmares in individuals with post-traumatic stress disorder (PTSD). This relationship underscores the role of nightmares in processing and integrating traumatic memories.

Genetic factors may also contribute to the likelihood of developing Nightmare Disorder. A twin study by Hublin et al. (1999) suggested a genetic predisposition to nightmares, indicating that there may be an inherited component to the disorder.

Moreover, the influence of medications and substances cannot be overlooked. Certain medications, particularly those affecting neurotransmitter systems, have been associated with an increased incidence of nightmares. Kales et al. (1980) reported that medications such as antidepressants and certain blood pressure drugs can increase the likelihood of experiencing vivid and distressing dreams.

Environmental factors like sleep habits and bedroom environment can also contribute to Nightmare Disorder. A study by Schredl (2009) found that poor sleep hygiene, irregular sleep patterns, and an uncomfortable sleep environment can exacerbate nightmare frequency.

In summary, the etiology of Nightmare Disorder is complex and includes psychological trauma, stress, genetic predisposition, the effects of certain medications, and environmental factors. This multifactorial origin suggests the need for a comprehensive approach to treatment and management.

Comorbidities

Nightmare Disorder is frequently associated with various comorbidities, encompassing both psychological and physical health conditions. The presence of these comorbidities can complicate the diagnosis and treatment of Nightmare Disorder.

One of the most common comorbidities of Nightmare Disorder is mental health disorders, particularly anxiety and mood disorders. A study by Li et al. (2010) found a significant association between frequent nightmares and depressive symptoms. This relationship suggests that nightmares may be a symptom or exacerbator of depressive states. Anxiety disorders, including generalized anxiety disorder and panic disorder, have also been linked to increased nightmare frequency, as indicated by Swart et al. (2013), who noted that heightened anxiety levels could contribute to the development or worsening of nightmares.

Post-traumatic stress disorder (PTSD) is another significant comorbidity. The role of nightmares in PTSD has been extensively studied, with findings by Germain et al. (2008) showing that nightmares are a core feature of PTSD, often involving re-experiencing traumatic events. This correlation underscores the importance of addressing nightmares in the treatment of PTSD.

Sleep disorders are also commonly comorbid with Nightmare Disorder. A study by Krakow et al. (2001) highlighted the prevalence of sleep apnea and restless legs syndrome in patients with chronic nightmares, suggesting a potential physiological link between these sleep disturbances and nightmares.

Furthermore, substance abuse and withdrawal have been associated with an increased incidence of nightmares. In research conducted by Brower et al. (2001), it was found that individuals with alcohol dependence often experience intense nightmares during withdrawal phases, which may persist even in long-term abstinence.

Physical health conditions, such as cardiovascular diseases and neurological disorders, can also co-occur with Nightmare Disorder. While the direct relationship is less clear, the stress and anxiety associated with chronic health conditions may contribute to the frequency or intensity of nightmares.

These comorbidities highlight the need for a holistic approach to the assessment and management of Nightmare Disorder, taking into account the potential interplay with other psychological and physical health issues.

Risk Factors

Several risk factors have been identified for Nightmare Disorder, ranging from psychological and physiological factors to lifestyle and environmental influences. Understanding these risk factors is crucial for the disorder's prevention and treatment.

Psychological stress and trauma are significant risk factors for Nightmare Disorder. Research by Levin and Nielsen (2007) highlighted that exposure to traumatic events and chronic stress can lead to an increased frequency of nightmares. This is particularly evident in individuals with post-traumatic stress disorder (PTSD), where nightmares often involve reliving traumatic experiences.

Mental health disorders, particularly anxiety and depression, are also associated with an increased risk of Nightmare Disorder. A study by Li et al. (2010) found a strong correlation between the severity of depressive symptoms and the frequency of nightmares. Similarly, anxiety disorders, including generalized anxiety disorder and panic disorder, have been linked to an increased incidence of nightmares.

Substance use and withdrawal, primarily from alcohol and certain medications, can increase the risk of developing Nightmare Disorder. Brower et al. (2001) noted that individuals with a history of alcohol dependence often experience intense nightmares, particularly during withdrawal phases.

Sleep disturbances, such as insomnia and sleep apnea, are also risk factors for Nightmare Disorder. Krakow et al. (2001) found that individuals with sleep disorders like sleep apnea often report frequent nightmares, suggesting a potential physiological link between sleep disturbances and nightmares.

Genetic predisposition may play a role in the development of Nightmare Disorder. A twin study by Hublin et al. (1999) suggested a hereditary component, indicating that individuals with a family history of nightmares or sleep disorders might be at higher risk.

Additionally, lifestyle factors such as irregular sleep patterns and poor sleep hygiene can contribute to the development of Nightmare Disorder. Schredl (2009) emphasized the importance of regular sleep schedules and a conducive sleep environment in preventing nightmares.

These risk factors collectively underscore the multifactorial nature of Nightmare Disorder, highlighting the importance of a comprehensive approach to its prevention and management.

Case Study

Chief Complaint: Steven, aged 19, presents with a complaint of frequent, distressing nightmares that have been occurring for several months. He reports that these nightmares often involve themes of danger and helplessness.

History of Present Illness: Steven's nightmares began around six months ago, occurring approximately three to four times a week. He describes them as vivid and terrifying, often waking him from sleep in a state of panic. Upon awakening, Steven is fully alert and has a detailed recollection of the nightmares. He notes increased anxiety around bedtime and difficulty returning to sleep after a nightmare. Steven reports feeling fatigued and irritable during the day due to disrupted sleep.

Past Psychiatric History: Steven reports a history of childhood trauma involving physical and emotional abuse. He has not received formal psychiatric treatment in the past but notes intermittent periods of anxiety and low mood since his early teenage years.

Family Psychiatric History: Steven is unaware of any family history of psychiatric conditions.

Medical History: Steven has good physical health and no chronic medical conditions. He does not take any regular medications.

Social History: Steven is a college student and lives in a dormitory. He describes having a small but supportive group of friends. He denies any use of alcohol, tobacco, or recreational drugs.

Mental Status Examination: Steven is alert and oriented to time, place, and person. His speech is coherent and goal-directed. He appears mildly anxious but is cooperative throughout the examination. His thought process is logical and linear. There is no evidence of delusions, hallucinations, or suicidal ideations. His mood is described as "worried," and his affect is congruent with his mood.

Diagnosis: Based on the DSM-5 criteria, Steven meets the diagnosis of Nightmare Disorder. His frequent, well-remembered, and distressing nightmares are causing significant distress and impairment in his social and academic functioning. The nightmares are not attributable to substance use or another medical condition. The history of childhood trauma is relevant, suggesting a potential psychological etiology for his nightmares.

Treatment Plan:

• Psychotherapy:Initiate cognitive-behavioral therapy (CBT), focusing on addressing Steven's traumatic experiences and providing him with coping strategies for anxiety and nightmares.
• Imagery Rehearsal Therapy (IRT):A specific type of CBT that involves changing the ending of the remembered nightmare while awake to reduce nightmare frequency and intensity.
• Sleep Hygiene Education:Provide education about maintaining consistent sleep-wake times, creating a comfortable sleep environment, and engaging in relaxing activities before bed.
• Follow-Up and Monitoring:Schedule regular follow-up appointments to monitor Steven's response to therapy and adjust the treatment plan as necessary.

Prognosis: With appropriate psychotherapeutic interventions, including specific therapies targeting nightmares and underlying trauma, there is a good chance of reducing the frequency and severity of Steven's nightmares and improving his overall quality of life.

Recent Psychology Research Findings

Psychology research has extensively investigated various aspects of Nightmare Disorder, contributing valuable insights into its prevalence, etiology, impact, and treatment options.

One significant area of study is the prevalence and impact of nightmares on the general population. A landmark study by Li et al. (2010) conducted a community-based survey to assess the prevalence of frequent nightmares. They found that 4.8% of their sample reported having nightmares, with a higher prevalence in females than males. The study also highlighted the strong association between nightmare frequency and psychiatric symptoms, particularly depression and anxiety, underlining the psychological impact of frequent nightmares.

In terms of etiology, the role of trauma in the development of Nightmare Disorder has been a focal point. A study by Germain et al. (2008) investigated the prevalence of nightmares in patients with post-traumatic stress disorder (PTSD). They found that nightmares were a common symptom in PTSD patients, with a significant number experiencing recurrent nightmares. This relationship between trauma and nightmares underscores the importance of addressing traumatic experiences in the treatment of Nightmare Disorder.

Treatment approaches for Nightmare Disorder have also been a significant area of research. Imagery Rehearsal Therapy (IRT), a cognitive-behavioral treatment, is effective. Krakow and Zadra (2006) conducted a study on the efficacy of IRT in reducing nightmare frequency and severity. Their results indicated that participants who underwent IRT experienced significant reductions in nightmare frequency and improved sleep quality and daytime functioning.

Additionally, the impact of Nightmare Disorder on sleep quality and overall health has been a subject of research. Nadorff et al. (2013) explored the relationship between nightmares, insomnia, and suicidal ideation. Their findings suggested a significant correlation between nightmare frequency and severity of insomnia symptoms, as well as an increased risk of suicidal thoughts and behaviors in individuals with frequent nightmares.

These studies contribute to a deeper understanding of nightmare disorder, highlighting its prevalence, potential causes, and effective treatment strategies. They also emphasize recognizing and addressing Nightmare Disorder as part of comprehensive mental health care.

Treatment and Interventions

The treatment and intervention of Nightmare Disorder have been a focus of considerable research, leading to the development of various therapeutic strategies aimed at reducing nightmare frequency and severity, as well as alleviating associated distress.

One of the most well-established treatments for Nightmare Disorder is Imagery Rehearsal Therapy (IRT), a form of cognitive-behavioral therapy. Krakow and Zadra (2006) conducted a study to evaluate the effectiveness of IRT in patients with chronic nightmares. The therapy involves changing the narrative of the nightmare by imagining a positive outcome while awake. Their study found that patients who underwent IRT reported significantly reduced nightmare frequency and improved sleep quality. Furthermore, the benefits of IRT were found to be sustained over time, indicating its long-term effectiveness.

Another therapeutic approach is Exposure, Relaxation, and Rescripting Therapy (ERRT), which combines exposure therapy with relaxation techniques and cognitive restructuring. A study by Davis et al. (2003) examined the effectiveness of ERRT in patients with Nightmare Disorder and PTSD. They found that ERRT not only reduced nightmare frequency but also led to improvements in PTSD symptoms and sleep quality.

Medication can also be used in the treatment of Nightmare Disorder, particularly in cases where nightmares are severe or resistant to psychotherapy. Prazosin, an alpha-1 adrenergic receptor antagonist, has been studied for its efficacy in reducing nightmares, especially in PTSD-related cases. A randomized clinical trial by Raskind et al. (2013) demonstrated that prazosin significantly reduced nightmare intensity and improved overall sleep quality in PTSD patients.

Mindfulness-based stress reduction (MBSR) has also been explored as a treatment option. A study by Ong et al. (2014) investigated the effects of MBSR on individuals with chronic nightmares. They found that participants who engaged in MBSR practices experienced reduced nightmare frequency and improved subjective sleep quality.

Finally, improving sleep hygiene is a critical component in managing Nightmare Disorder. This involves establishing a regular sleep schedule, creating a comfortable sleep environment, and avoiding stimulants before bedtime. Schredl (2009) emphasized the importance of good sleep hygiene in reducing the frequency of nightmares and improving overall sleep quality.

These treatment strategies highlight the multifaceted approach required to effectively manage Nightmare Disorder, combining psychological therapies, pharmacological interventions, and lifestyle modifications.

Implications if Untreated

The implications of untreated Nightmare Disorder can be profound and far-reaching, affecting various aspects of an individual's life. Research in this area has highlighted several potential consequences.

One of the primary concerns is the impact on mental health. A study by Li et al. (2010) demonstrated a strong correlation between frequent nightmares and the development or exacerbation of psychiatric conditions, particularly depression and anxiety. Their research indicated that individuals with frequent nightmares were more likely to report symptoms of depression and anxiety, suggesting that untreated Nightmare Disorder can contribute to or worsen these conditions.

Sleep quality is another significant area affected by untreated Nightmare Disorder. Nadorff et al. (2013) conducted a study exploring the relationship between nightmares and sleep disturbances. They found that individuals with frequent nightmares often experience poor sleep quality, including difficulty falling asleep and staying asleep, leading to chronic sleep deprivation. This can result in daytime fatigue, reduced cognitive function, and impaired overall daily functioning.

The potential for developing other sleep disorders is also a concern. Krakow et al. (2001) found that individuals with untreated Nightmare Disorder might be at an increased risk for other sleep disorders, such as insomnia and sleep apnea. This comorbidity can create a complex clinical picture that is more challenging to treat.

Furthermore, there are implications for physical health. A study by Sjöström et al. (2009) highlighted the association between chronic nightmares and cardiovascular health. They reported that persistent nightmares might be linked to an increased risk of hypertension and other cardiovascular conditions, possibly due to the chronic stress and sleep disruption caused by frequent nightmares.

Lastly, untreated Nightmare Disorder can impact social and occupational functioning. The distress and sleep disturbance caused by nightmares can lead to difficulties in maintaining personal relationships, job performance, and overall quality of life, as indicated by Swart et al. (2013).

These studies underscore the importance of recognizing and treating Nightmare Disorder to mitigate these potential adverse outcomes.

Summary

Nightmare Disorder, historically misunderstood and often overlooked, presents a challenging clinical entity, both in terms of diagnosis and treatment. Over the years, the perspective on this disorder has evolved significantly, shifting from a mere nocturnal inconvenience to a recognized psychiatric condition with substantial impacts on overall well-being.

The diagnostic journey of Nightmare Disorder has been complex. Initially, nightmares were often dismissed as mere products of the imagination or stress, with little clinical significance. However, the perspective shifted as our understanding of sleep and its disorders improved. Studies like that of Krakow et al. (2001) helped in highlighting the distress and functional impairments associated with frequent nightmares, leading to more robust diagnostic criteria and treatment approaches.

Nightmare Disorder's impact on personal identity and relationships is profound. Recurrent nightmares can lead to a sense of loss of control, affecting an individual's self-perception and confidence. The strain of chronic sleep disturbance can also disrupt interpersonal relationships. Nadorff et al. (2013) discussed the potential for increased irritability and decreased patience, which can strain personal and professional relationships.

The ability to function in daily life is notably affected. The research by Li et al. (2010) demonstrated the correlation between frequent nightmares and psychiatric symptoms like depression and anxiety, which can significantly impair daily functioning. This is compounded by sleep disturbances that lead to daytime fatigue, reduced cognitive function, and decreased productivity.

From a historical and evolving perspective, there has been a shift towards a more inclusive and compassionate understanding of Nightmare Disorder. This is evident in the growing recognition of the disorder in various clinical guidelines and the development of specific treatments, such as Imagery Rehearsal Therapy (Krakow & Zadra, 2006) and Exposure, Relaxation, and Rescripting Therapy (Davis et al., 2003). These therapies not only address the nightmares themselves but also the underlying psychological distress, reflecting a more holistic approach to treatment.

In summary, Nightmare Disorder is a complex condition that extends beyond the realm of sleep, affecting various facets of an individual's life. The evolution in understanding and treating this disorder underscores the importance of a comprehensive approach, considering the interplay between sleep, psychological health, and overall quality of life.

References

Aurora, R. N., Zak, R. S., Maganti, R. K., Auerbach, S. H., Casey, K. R., Chowdhuri, S., ... & Morgenthaler, T. I. (2010). Best practice guide for the treatment of nightmare disorder in adults. Journal of Clinical Sleep Medicine, 6(4), 389-401.

Brower, K. J., Aldrich, M. S., Robinson, E. A., Zucker, R. A., & Greden, J. F. (2001). Insomnia, self-medication, and relapse to alcoholism. American Journal of Psychiatry, 158(3), 399-404.

Davis, J. L., Wright, D. C., & Borntrager, C. L. (2003). A case series utilizing exposure, relaxation, and rescripting therapy: Impact on nightmares, sleep quality, and psychological distress. Behavioral Sleep Medicine, 1(3), 151-157.

Germain, A., Hall, M., Krakow, B., Shear, M. K., & Buysse, D. J. (2008). A brief sleep scale for Posttraumatic Stress Disorder: Pittsburgh Sleep Quality Index Addendum for PTSD. Journal of Anxiety Disorders, 22(2), 233–244.

Hartmann, E. (1998). Nightmares and human conflict. Journal of Clinical Psychiatry, 59(Suppl 10), pp. 16–22.

Hublin, C., Kaprio, J., Partinen, M., Heikkilä, K., & Koskenvuo, M. (1999). Heritability and mortality risk of insomnia-related symptoms: a genetic epidemiologic study in a population-based twin cohort. Sleep, 22(5), 627-635.

Kales, A., Soldatos, C. R., Bixler, E. O., Kales, J. D. (1980). Early morning insomnia with rapidly eliminated benzodiazepines. Science, 207(4426), 200-202.

Krakow, B., & Zadra, A. (2006). Clinical management of chronic nightmares: Imagery rehearsal therapy. Behavioral Sleep Medicine, 4(1), 45-70.

Krakow, B., Melendrez, D., Johnston, L., Warner, T. D., Clark, J. O., & Pacheco, M. (2001). Sleep dynamic therapy for Cerro Grande Fire evacuees with posttraumatic stress symptoms: a preliminary report. Journal of Clinical Psychiatry, 62(9), 673-684.

Levin, R., & Nielsen, T. A. (2007). Disturbed dreaming, posttraumatic stress disorder, and affect distress: A review and neurocognitive model. Psychological Bulletin, 133(3), 482-528.

Li, S. X., Zhang, B., Li, A. M., & Wing, Y. K. (2010). Prevalence and correlates of frequent nightmares: a community-based 2-phase study. Sleep, 33(6), 774–780.

Nadorff, M. R., Nazem, S., & Fiske, A. (2013). Insomnia symptoms, nightmares, and suicidal ideation in a college student sample. Sleep, 36(1), 93-98.

Ong, J. C., Shapiro, S. L., & Manber, R. (2014). Combining mindfulness meditation with cognitive-behavior therapy for insomnia: A treatment-development study. Behavior Therapy, 45(3), 359–370.

Raskind, M. A., Peterson, K., Williams, T., Hoff, D. J., Hart, K., Holmes, H., ... & Peskind, E. R. (2013). A trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan. American Journal of Psychiatry, 170(9), 1003–1010.

Schredl, M. (2009). Nightmares: An under-diagnosed and undertreated condition? Sleep Medicine Reviews, 13(3), 227–234.

Sjöström, N., Waern, M., & Hetta, J. (2009). Nightmares and sleep disturbances in relation to suicidality in suicide attempters. Sleep, 32(6), 839-844.

Swart, M. L., van Schagen, A. M., Lancee, J., & van den Bout, J. (2013). Prevalence of nightmare disorder in psychiatric outpatients. Psychotherapy and Psychosomatics, 82(4), 267-268.